Use of romiplostim for antineoplastic therapy-induced thrombocytopenia in gynecologic and breast cancers

• Main Authors: Sara Moufarrij (Author), Roisin E. O'Cearbhaill (Author), Qin Zhou (Author), Alexia Iasonos (Author), Simon Mantha (Author), Jeffrey Zwicker (Author), Cy R. Wilkins (Author)
• Format: Book
• Published: Elsevier, 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objective: Romiplostim is used to treat chemotherapy-induced thrombocytopenia in a variety of tumor types; however, few studies have examined its use in breast and gynecologic cancers. We evaluated platelet response and durability of response to romiplostim in patients with gynecologic or breast can...